⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
VTGN Stockholders Have Opportunity to Lead Vistagen Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
VTGN
Pomerantz LLP Reminds Shareholders with Losses on their Investment in Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
Pomerantz LLP Reminds Shareholders with Losses on their Investment in Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - VTGN
globenewswire.com
VTGN
VTGN FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) Seeking Recovery for Investors – Contact The Gross Law Firm
globenewswire.com
VTGN
VTGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026
accessnewswire.com
VTGN
Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN